These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

313 related articles for article (PubMed ID: 30612698)

  • 1. [Some important breakthroughs in oncology and hematology in 2018: A selection by the editorial board of Bulletin du Cancer].
    Bay JO; André T; Caux C; Evrard S; Gonçalves A; L'Allemain G; Magné N; Orbach D; Penel N; Rodrigues M; Thariat J; Thiery-Vuillemin A; Wislez M;
    Bull Cancer; 2019 Jan; 106(1):12-23. PubMed ID: 30612698
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Which recent results in Oncology and Hematology will have an impact on our practices? The point of vue of Bulletin du Cancer editorial board].
    Vignot S; André T; Gonçalves A; Guièze R; Magné N; Orbach D; Penel N; Thariat J; Wislez M; Bay JO
    Bull Cancer; 2017 Jan; 104(1):6-19. PubMed ID: 28007296
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Hot topics in 2017 in oncology and hematology. A selection by the editorial board of Bulletin du Cancer].
    Vignot S; André T; Caux C; Bouleuc C; Evrard S; Gonçalves A; Lacroix M; Magné N; Massard C; Mazeron JJ; Orbach D; Rodrigues M; Thariat J; Wislez M; L'Allemain G; Bay JO
    Bull Cancer; 2018 Jan; 105(1):6-14. PubMed ID: 29269176
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Major advances in oncology in 2014: the editorial board of the Bulletin du Cancer point of view].
    Massard C; Bay JO; André T; Blay JY; Goncalves A; Orbach D; Wislez M; Thariat J; Magné N; Vignot S
    Bull Cancer; 2015 Jan; 102(1):92-104. PubMed ID: 25609486
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [What should we remember from 2020?].
    Bay JO; Andre T; Bouleuc C; Gandemer V; Magne N; Orbach D; Pellier I; Penel N; Rodrigues M; Thariat J; Thiery-Villemin A; Wisley M; L'Allemain G; Robert J;
    Bull Cancer; 2021 Jan; 108(1):55-66. PubMed ID: 33419531
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [A 2021 inventory in oncology news].
    Bay JO; Bouleuc C; Firmin N; Gandemer V; Magne N; Orbach D; Penel N; Rodrigues M; Thiery-Vuillemin A; Wislez M; L'Allemain G; Sabatier R; Robert J;
    Bull Cancer; 2022 Jan; 109(1):8-19. PubMed ID: 34980367
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The changing face of clinical trials in the personalized medicine and immuno-oncology era: report from the international congress on clinical trials in Oncology & Hemato-Oncology (ICTO 2017).
    Golan T; Milella M; Ackerstein A; Berger R
    J Exp Clin Cancer Res; 2017 Dec; 36(1):192. PubMed ID: 29282151
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [2015 through the eyes of the Bulletin of Cancer editorial board].
    Magné N; Massard C; Bay JO; André T; Blay JY; Goncalves A; Orbach D; Wislez M; Thariat J; Penel N; Rancoule C; Vignot S
    Bull Cancer; 2016 Jan; 103(1):3-17. PubMed ID: 26782079
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Major advances in Oncology in 2013: the editorial board of the Bulletin du Cancer point of view].
    Vignot S; Bay JO; André T; Blay JY; Goncalves A; Massard C; Orbach D; Wislez M; Thariat J; Magné N
    Bull Cancer; 2014 Jan; 101(1):75-92. PubMed ID: 24491669
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New frontiers of therapy in hemato-oncology.
    Prabhash K; Bapsy PP
    J Assoc Physicians India; 2003 Nov; 51():1123-4; author reply 1124. PubMed ID: 15260408
    [No Abstract]   [Full Text] [Related]  

  • 11. [American Society of Clinical Oncology (ASCO) 2011 essential data: the editorial board of the Bulletin du Cancer point of view].
    Vignot S; Bay JO; Blay JY; Gonçalves A; Massard C; Thariat J; Wislez M; André T
    Bull Cancer; 2011 Dec; 98(12):1509-23. PubMed ID: 22182714
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Following communications made at American Society of Clinical Oncology 2010, what will change our practice? The point of view of the editorial board of Bulletin du Cancer].
    André T; Wislez M; Goncalves A; de La Motte Rouge T; Blay JY; Massard C; Bay JO;
    Bull Cancer; 2010 Dec; 97(12):1551-62. PubMed ID: 21220230
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Future-oriented hemato-oncology in times of confusion in health politics].
    Niederwieser D; Hiddemann W
    Dtsch Med Wochenschr; 2006 Oct; 131(43):2385. PubMed ID: 17054052
    [No Abstract]   [Full Text] [Related]  

  • 14. [American Society of Clinical Oncology (ASCO) 2012 essential data: the editorial board of the Bulletin du Cancer point of view].
    Magné N; Bay JO; Blay JY; Gonçalves A; Massard C; Thariat J; Wislez M; André T; Vignot S
    Bull Cancer; 2012 Dec; 99(12):1209-17. PubMed ID: 23306389
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Building a National Framework for Adolescent and Young Adult Hematology and Oncology and Transition from Pediatric to Adult Care: Report of the Inaugural Meeting of the "AjET" Working Group of the German Society for Pediatric Oncology and Hematology.
    Escherich G; Bielack S; Maier S; Braungart R; Brümmendorf TH; Freund M; Grosse R; Hoferer A; Kampschulte R; Koch B; Lauten M; Milani V; Ross H; Schilling F; Wöhrle D; Cario H; Dirksen U
    J Adolesc Young Adult Oncol; 2017 Jun; 6(2):194-199. PubMed ID: 27983882
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Highlights of the third International Conference on Immunotherapy in Pediatric Oncology.
    Brehm C; Huenecke S; Pfirrmann V; Rossig C; Mackall CL; Bollard CM; Gottschalk S; Schlegel PG; Klingebiel T; Bader P
    Pediatr Hematol Oncol; 2013 Aug; 30(5):349-66. PubMed ID: 23758210
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical development of immuno-oncology in China.
    Wu DW; Huang HY; Tang Y; Zhao Y; Yang ZM; Wang J; Wang SH; Yu Y; Fang Y; Fang H; Bai Y; Sun C; Fan Q; Yu AQ; Wang HL; Du CX; Chen K; Huang MD; Zhang Y; Li N; Xu BH; Sun Y; He J
    Lancet Oncol; 2020 Aug; 21(8):1013-1016. PubMed ID: 32758460
    [No Abstract]   [Full Text] [Related]  

  • 18. Landscape of early clinical trials for childhood and adolescence cancer in Spain.
    Bautista F; Gallego S; Cañete A; Mora J; Diaz de Heredia C; Cruz O; Fernández JM; Rives S; Madero L; Castel V; Cela ME; Ramírez G; Sábado C; Acha T; Astigarraga I; Sastre A; Muñoz A; Guibelalde M; Moreno L
    Clin Transl Oncol; 2016 Jul; 18(7):708-13. PubMed ID: 26489424
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hematological malignancies: a primer.
    Haddad RY
    Dis Mon; 2012 Apr; 58(4):151-2. PubMed ID: 22449364
    [No Abstract]   [Full Text] [Related]  

  • 20. [Immunotherapy in lung cancer: New concepts].
    Goubet AG; Livartowski A; Romano E
    Rev Mal Respir; 2018 Jun; 35(6):642-651. PubMed ID: 29941206
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.